Skip to main content

Medical Marijuana and Other Alternative Therapies

October 17, 2019

This is an archived file of an event that took place on Thursday, October 17, 2019.

Our panelists discuss what research is finding about marijuana use for Parkinson's disease and the role of other therapies such as acupuncture and meditation. The speakers and our staff answer questions from the audience.

Webinar Details


Thursday, October 17, 2019


1 hr


12:00 pm ET
  • MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: October 17, 2019
    Date Credit Expires: October 17, 2021

    Learning Objectives
    • Define complementary and alternative medicine and integrative medicine.
    • Describe the scientific rationale for medical marijuana in Parkinson’s, research findings on Parkinson’s motor and non-motor symptoms, and challenges in medical marijuana research.
    • Discuss care considerations around medical marijuana in Parkinson’s.
    • Explain the potential role of acupuncture, meditation, reiki and certain forms of exercise in treating Parkinson’s motor and non-motor symptoms.
    • Summarize the evidence on dietary supplements in Parkinson’s.
    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Oakstone Publishing has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Soania Mathur, BSc, MD, CCFP - Moderator
    Co-chair, MJFF Patient Council
    Nothing to disclose

    Matt Ackerman
    MJFF Patient Council member
    Nothing to disclose

    Susan Fox, MB ChB, MRCP(UK), PhD
    Director, Division of Neurology
    University of Toronto
    Disclosures -- Advisory Role: Atuka, Acadia, Sunovion, Teva

    Benzi M. Kluger, MD, MS
    Professor, Department of Neurology
    University of Colorado

    Helen Lavretsky, MD, MS
    Professor In-Residence, Department of Psychiatry
    Disclosures -- Research Grants: Allergan

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.